Professor of Pediatrics, University Tenn College of Medicine
Pediatric Infectious Disease
Dr. John Devincenzo, MD
|
|
Give Review
Doctor John Devincenzo, MD practices Pediatric Infectious Disease. He studied medicine at Vanderbilt University School of Medicine. John Devincenzo is a published doctor and has 73 publications published. The lastest was: 'Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein.'
Publications
- Challenges and opportunities in developing respiratory syncytial virus therapeutics.
- Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis.
- Oral GS-5806 activity in a respiratory syncytial virus challenge study.
- Within-Host Whole-Genome Deep Sequencing and Diversity Analysis of Human Respiratory Syncytial Virus Infection Reveals Dynamics of Genomic Diversity in the Absence and...
- Limited Type I IFNs and Plasmacytoid Dendritic Cells during Neonatal Respiratory Syncytial Virus Infection Permit Immunopathogenesis upon Reinfection.
- Multi-center evaluation of the adenovirus R-gene US assay for the detection of adenovirus in respiratory samples.
- Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.
- HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection.
- Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals.
- Molecular detection and quantification of pertussis and correlation with clinical outcomes in children.
- Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children.
- Respiratory syncytial virus load and disease severity in the community.
- Viral load drives disease in humans experimentally infected with respiratory syncytial virus.
- Surfactant protein A2 polymorphisms and disease severity in a respiratory syncytial virus-infected population.
- RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy.
- Safety and antiviral activity of motavizumab, a respiratory syncytial virus (RSV)-specific humanized monoclonal antibody, when administered to RSV-infected children.
- Human genetic factors and respiratory syncytial virus disease severity.
- RNA interference strategies as therapy for respiratory viral infections.
- 2007 International Congress on Respiratory Viruses. Introduction.
- Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age.
- A new direction in understanding the pathogenesis of respiratory syncytial virus bronchiolitis: how real infants suffer.
- Group B streptococcal ventriculitis: a report of three cases and literature review.
- A new non-surgical approach for treatment of extreme dolichocephalic malocclusions. Part 2. Case selection and management.
- A new non-surgical approach for treatment of extreme dolichocephalic malocclusions. Part 1. Appliance design and mechanotherapy.
- Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner.
- Factors predicting childhood respiratory syncytial virus severity: what they indicate about pathogenesis.
- Respiratory syncytial virus load predicts disease severity in previously healthy infants.
- Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respira...
- Natural infection of infants with respiratory syncytial virus subgroups A and B: a study of frequency, disease severity, and viral load.
- Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants.
- Respiratory syncytial virus (RSV) loads in premature infants with and without prophylactic RSV fusion protein monoclonal antibody.
- Relationship between respiratory syncytial virus load and illness severity in children.
- A cephalometric study of the Class II correction effects of the Eureka Spring.
- A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome.
- Respiratory syncytial virus human experimental infection model: provenance, production, and sequence of low-passaged memphis-37 challenge virus.
- Ehrlichia chaffeensis seroprevalence among children in the southeast and south-central regions of the United States.
- Respiratory virus infections in pediatric hematopoietic stem cell transplantation.
- Twin-block appliance therapy.
- Adenovirus 7a: a community-acquired outbreak in a children's hospital.
- Therapy of respiratory syncytial virus infection.
- Pre-emptive ribavirin for ''RSV'' in BMT.
- Nasal quantity of respiratory syncytical virus correlates with disease severity in hospitalized infants.
- Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassiona...
- Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentration and correlate results with inflammatory mediators in tracheal secretions.
- Multidrug-resistant tuberculosis meningitis: clinical problems and concentrations of second-line antituberculous medications.
- Oerskovia xanthineolytica peritonitis: case report and review.
- Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein.
- Prevention and treatment of respiratory syncytial virus infections (for advances in pediatric infectious diseases).
- The Eureka Spring: a new interarch force delivery system.
- Emerging and newly identified viral infections.
- Prolonged thalidomide therapy for human immunodeficiency virus-associated recurrent severe esophageal and oral aphthous ulcers.
- Mild herpes simplex encephalitis diagnosed by polymerase chain reaction: a case report and review.
- Maxillary incisor intrusion and facial growth.
- A study in human subjects using a new device designed to mimic the protrusive functional appliances used previously in monkeys.
- More on mandibular advancement surgery.
- Orthopedic and orthodontic effects resulting from the use of a functional appliance with different amounts of protrusive activation.
- Response to Clark's comments in March issue.
- More on static magnetic fields.
- Changes in mandibular length before, during, and after successful orthopedic correction of Class II malocclusions, using a functional appliance.
- Respiratory syncytial virus infections in the pediatric intensive care unit: clinical characteristics and risk factors for adverse outcomes.
- Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States.
- Time and out-of-pocket costs associated with respiratory syncytial virus hospitalization of infants.
- Opportunities for early therapy of respiratory syncytial virus (RSV) infection: what happens before hospitalization.
- Quantitative effects of palivizumab and donor-derived T cells on chronic respiratory syncytial virus infection, lung disease, and fusion glycoprotein amino acid sequen...
- Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV).
- Passive antibody prophylaxis for RSV.
- Effect of dexamethasone on respiratory syncytial virus-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial.
- Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
- A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus.
- N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.
- RNA interference therapy in lung transplant patients infected with respiratory syncytial virus.
- The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses.
Doctors Specialties
- Pediatric Infectious Disease Medicine
- Pediatric Infectious Disease
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Network S
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Emblem Health
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
UCLA Medical Center -
Vanderbilt University School of Medicine
Hospital
-
Le Bonheur Children's Hospital
Helpful Reviews
Similar Doctors
|
Dr. Elaine I. Tuomanen, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Patricia J. Chesney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miguela A. Caniza, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sandra Arnold, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Boyce K. English, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan A. McCullers, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Gabriela M. Maron, MD |
|
|
Dr. Nicholas D. Hysmith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Aditya H. Gaur, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy D. Minniear, MD
This Doctor is OpenDoctor Recommended.
|